Akums bags key EU GMP certifications for 2 Haridwar plants
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Subscribe To Our Newsletter & Stay Updated